Prostate brachytherapy: A review of current practice

Journal of Radiotherapy in Practice

Volumn 4, Issue 2-3, 2004, Pages 86-101

  Bownes, Peter ^a   Flynn, Anthony ^b  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b Northern and Yorkshire Clinical Trials and Research Unit   (United Kingdom)

Author keywords

Brachytherapy; HDR; LDR; Prostate cancer

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; GOLD 198; IODINE 125; IRIDIUM 192; PALLADIUM 103; PLATINUM 192; PLATINUM DERIVATIVE; SUTURE MATERIAL; UNCLASSIFIED DRUG;

AGING; ARTICLE; BRACHYTHERAPY; CANCER INCIDENCE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DEFECATION DISORDER; DOSIMETRY; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG STABILITY; HUMAN; IMAGING SYSTEM; INTENSITY MODULATED RADIATION THERAPY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PEROPERATIVE CARE; PERSONNEL RADIATION MONITORING; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PROSTATE CANCER; PUBLISHING; QUALITY CONTROL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RADIATION PROTECTION; RADIOISOTOPE DECAY; TREATMENT PLANNING; URINARY TRACT DISEASE;

EID: 26844533463     PISSN: 14603969     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1460396905000130     Document Type: Article

References (52)

1. Office of National Statistics (www.statistics.gov.uk).
2. Institute of Health Science (www.ihs.ox.ac.uk).
3. Institute of Cancer Research (www.icr.ac.uk).
4. Evans S, Møller H. Recent trends in prostate cancer incidence and mortality in southeast England. Eur Urol 2003; 43: 337-341.
5. Nag S, Beyer D, Friedland J, Grimm P, Nath R. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiol Oncol Biol Phys 1999; 44(4): 789-799.
6. Ash D, Flynn A, Battermann J, de Reijke T, Lavagnini P, Blank L, ESTRO/ EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 2000; 57: 315-321.
7. Ragde H, Grado GL, Nadir BS. Brachytherapy for clinically localized prostate cancer: Thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone. Arch Esp Urol 2001; 54(7): 739-747.
8. Blasko JC, Mate T, Sylvester JE, Grimm PD, Cavanagh W. Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomes. Semin Radiat Oncol 2002; 12(1): 81-94.
9. Stone NN, Stock RG. Complications following permanent prostate brachytherapy. Eur Urol 2002; 41(4): 427-433.
10. Norderhaug I, Dahl O, Hoisaeter PA, et al. Brachytherapy for prostate cancer: A systematic review of clinical and cost effectiveness. Eur Urol 2003; 44(1): 40-46.
11. Holm HH. The history of interstitial brachytherapy of prostatic cancer. Semin Surg Oncol 1997; 13: 431-437.
12. Barringer BS. Radium in the treatment of cancer of the bladder and prostate. JAMA 1917; 68: 1227-1230.
13. Whitmore WF Jr, Hilaris B, Grabstald H. Retropubic implantation to iodine 125 in the treatment of prostatic cancer. J Urol 1972; 108(6): 918-920.
14. Battermann JJ, Boon TA, de Voogt HJ. Preliminary results with iodine-125 seeds for permanent implantation in patients with localized prostatic cancer. Radiother Oncol 1987; 10(2): 91-95.
15. Zelefsky MJ, Whitmore WF Jr. Long-term results of retropubic permanent 125-iodine implantation of the prostate for clinically localized prostatic cancer. J Urol 1997; 158(1): 23-29.
16. Battermann JJ. I-125 implantation for localized prostate cancer: The Utrecht University experience. Radiother Onco 2000; 57(3): 269-272.
17. Kovacs G, Wirth B, Bertermann, H, et al. Prostate preservation by combined external beam and HDR brachytherapy at nodal negative prostate cancer patients - an intermediate analysis after ten years experience. Int J Radiat Oncol Biol Phys 1996; 36(suppl): S80,198.
18. Mate T, Gottesman J, Hatton J, et al. High dose rate after-loading iridium-192 prostate brachytherapy. Feasibility Report. Int J Rad Oncol Biol Phys 1998; 41(3): 525-533.
19. Stromberg J, Martinez A, Gonzalez J, et al. Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: Treatment description and preliminary results of a Phase 1/11 Clinical Trial. Int J Radiat Oncol Biol Phys 1995; 33: 161-171.
20. Partin AW, Subong ENP, Walsh PC, et al. Clinical stage and Gleason score to predict pathological stage of localised prostate cancer. J Am Med Assoc 1997; 17: 1191-1197.
21. Ash D, Bottomley D, Carey BM. Prostate brachytherapy (Review). Prostate Cancer and Prostatic Diseases. Stockton Press, 1998: 185-188.
22. Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS. Dosimetry of interstitial brachytherapy sources. Report of AAPM Radiation Therapy Committee Task Group 43. Med Phys 1995; 22(2): 209-233.
23. Corbett JF, Jezioranski JJ, Crook J, Tran T, Yeung IW. The effect of seed orientation deviations on the quality of 1251 prostate implants. Phys Med Biol 2001; 46(11): 2785-2800.
24. Nag S. Brachytherapy for prostate cancer: Summary of American Brachytherapy Society recommendations. Semin Urol Oncol 2000; 18(2): 133-136.
25. Stock RG, Stone NN, Tabert A, Ianuzzi C, De Wyngaert JK. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys 1998; 41(1): 101-108.
26. Potters L, Cao Y, Calugaru E, Torre T, Fearn P, Wang X. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2001; 50(3): 605-614.
27. Nag S, Bice W, Dewyngaert K, Prestidge B, Stock R, Yu Y. The American Brachytherapy Society recommendations for permanent prostate brachytherapy post implant dosimetric analysis. Int J Radiat Oncol Biol Phys 2000; 46(1): 221-230.
28. Smathers S, Wallner K, Korssjoen T, et al. Radiation safety parameters following prostate brachytherapy. Int J Radiat Oncol Biol Phys 1999; 45(2): 397-399.
29. Michalski J, Mutic S, Eichling J, Ahmed SN. Radiation exposure to family and household members after prostate brachytherapy. Int J Radiat Oncol Biol Phys 2003; 56(3): 764-768.
30. Martinez A, Pataki I, Edmundson G, et al. Phase II prospective study of the use of conformal high-dose rate brachytherapy as monotherapy for the treatment of favourable stage prostate cancer. Int J Radiat Oncol Biol Phys 2001; 50: 61-69.
31. Yoshioka Y, Nose T, Yoshida K, et al. High-dose-rate brachytherapy as monotherapy for localised prostate cancer: A retrospective analysis with special focus on tolerance and chronic toxicity. Int J Radiat Oncol Biol Phys 2001; 50(3): 605-614.
32. Hoskin PJ. High dose rate brachytherapy boost treatment in radical radiotherapy for prostate cancer. Radiother Oncol 2000; 57: 285-288.
33. Hoskin PJ. High dose rate afterloading for brachytherapy for prostate cancer. In: Principles and Practice of Brachytherapy (eds: CAF Joslin, A Flynn and EJ Hall) London: Arnold, 2001.
34. Martin T, Kolotas C, Dannenberg T, et al. New interstitial HDR brachytherapy technique for prostate cancer: CT based 3D planning after transrectal implantation. Radiother and Oncol 1999; 52: 257-260.
35. Rodrigues R, Demanes DJ. HDR brachytherapy: Ultimate in conformal radiotherapy for the treatment of prostate cancer. In: New developments in Interstitial Remote Controlled Brachytherapy (ed: Zambogolou). Munich: W Zuckschwerd und Verlag, 1997; 119-125.
36. Dinges S, Deger S, Koswig S, et al. High dose rate interstitial with external beam irradiation for localised prostate cancer - results of a prospective trial. Radiother Oncol 1998; 48: 197-202.
37. Borghede G, Hedelin H, Holmang S, et al. Irradiation of localised prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland. Radiother Oncol 1997; 44: 245-250.
38. Martinez A, Gustafson G, Gonzalez J, et al. Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavourable, prostate cancer. Int J Radiat Oncol Biol Phys 2002; 53: 316-327.
39. Brenner DJ, Hall EJ. Fractionation for radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1999; 43: 1095-1101.
40. Fowler J, Chappell R, Ritter M. Is alpha/beta for prostate tumours really low? Int J Radiat Oncol Biol Phys 2001; 50: 1021-1031.
41. Diez P, Bownes PJ, Hoskin PJ, Ostler PJ, Aird EGA. Optimising of prostate cancer radiotherapy using high dose brachytherapy: A radiobiological analysis. Clin Oncol 2003; 15 (suppl 2): S11.
42. MRC Radiotherapy working Group. RTO1 A randomised trial of high dose therapy in localised cancer of the prostate using conformal radiotherapy techniques. May 2000, version 2.
43. Hoskin PJ, Bownes PJ, Ostler PJ, Bryant L. The effect of catheter movement on implant quality for fractionated high dose rate afterloading brachytherapy of prostate cancer. Radiother Oncol 2003; 68: 285-288.
44. Martinez A, Gonzalez J, Stromberg J, et al. Conformal prostate brachytherapy: Initial experience of a phase I/II dose escalating trial. Int J Radiat Oncol Biol Phys 1995; 33: 1019-1027.
45. Damore SJ, Syed N, Puthawala, et al. Needle displacement during HDR brachytherapy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 2000; 41: 1205-1211.
46. Mullokandov E, Gejerman G. Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy. Int J Radiat Oncol Biol Phys 2004; 58: 1063-1071.
47. ASTRO Consensus Statement: Guidelines for PSA following radiation treatment. Int J Rad Oncol Biol Phys 1997; 37: 1035-1041.
48. Nag S, Ciezki JP, Cormack R, et al. Intraoperative planning and evaluation of permanent prostate brachytherapy: Report of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 2001; 51(5): 1422-1430.
49. Al-Qaisieh B, Ash D, Bottomley DM, Carey BM. Impact of prostate volume evaluation by different observers on CT-based post-implant dosimetry. Radiother Oncol 2002; 62(3): 267-273.
50. Al-Qaisieh B. Pre- and post-implant dosimetry: An intercomparison between UK prostate brachytherapy centres. Radiother Oncol 2003; 66(2): 181-183.
51. Cumberlin RL, Coleman CN. New directions in brachytherapy. Int J Radiat Oncol Biol Phys 2002; 53: 6-11.
52. Van Der Laarse, Luthmann RW. Computers in Brachytherapy Dosimetry. In: Principles and Practice of Brachytherapy (ed: CAF Joslin, A Flynn and EJ Hall). London: Arnold, 2001.